Neut-X can be successfully used as diagnostic and prognostic tool in MDS

Leuk Res. 2019 Nov:86:106224. doi: 10.1016/j.leukres.2019.106224. Epub 2019 Sep 13.

Authors

Amelie Boquoi¹, Carmen Barthuber², Judith Strapatsas², Andrea Kuendgen², Guido Kobbe², Roland Fenk², Norbert Gattermann², Rainer Haas², Ulrich Germing²

Affiliations

¹ Universitätsklinikum Düsseldorf, Heinrich-Heine-University, Moorenstr. 5, Düsseldorf, 40225, Germany. Electronic address: amelie.boquoi@med.uni-duesseldorf.de.
² Universitätsklinikum Düsseldorf, Heinrich-Heine-University, Moorenstr. 5, Düsseldorf, 40225, Germany.

PMID: 31586853
DOI: 10.1016/j.leukres.2019.106224

No abstract available

Publication types

Letter

MeSH terms

Aged
Biomarkers, Tumor
Case-Control Studies
Female
Follow-Up Studies
Hematologic Tests
Humans
Male
Myelodysplastic Syndromes / blood*
Myelodysplastic Syndromes / diagnosis*
Neutrophils / pathology*
Prognosis
Survival Rate

Substances

Biomarkers, Tumor